Biparametric MRI in prostate cancer during active surveillance: is it safe?
Authors (first, second and last of 5)
Collection
Active surveillance of prostate cancer: MRI and beyond
A key challenge in prostate cancer is to distinguish cancers which need treating from those which do not. Magnetic resonance imaging allows a detailed non-invasive prostate assessment and might allow patients on active surveillance with low- or favourable intermediate-risk disease to defer or even avoid repeat biopsies if image quality and reporting are of the highest standard and if there are no signs of clinical and radiological progression.
European Radiology has dedicated an article collection to the role for MRI (and other imaging tools) in active surveillance of prostate cancer. This article collection aims to gather all articles relevant to this strategy of prostate cancer management in one place, so that researchers and clinicians can easily access reviews, original articles and commentaries on the subject. The article collection will remain open; manuscripts can be submitted freely to the journal and will be added to the collection upon publication. Submissions are subject to the rigorous peer review the journal conducts for all unsolicited manuscripts. Peer review is steered by Francesco Giganti, a leading scientist in the field.
Editors
-
Prof. Francesco Giganti
Associate Professor of Radiology, Faculty of Medical Sciences, University College London, London, UK Francesco is Associate Professor of Radiology at UCL and Honorary Consultant Radiologist at UCLH. He is an expert in teaching prostate MRI for radiologists and urologists, and part of the team commissioned by European Association of Urology to deliver Europe-wide training course in prostate MRI. His main areas of interest in prostate MRI are active surveillance (PRECISE score), image quality (PI-QUAL score), and imaging after focal ablation (PI-FAB score).
-
Prof. Rossano Girometti
Institute of Radiology, Department of Medicine, University of Udine (Italy) and Institute of Radiology, University Hospital S. Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Udine, Italy Rossano Girometti, Associate Professor of Radiology, is devoted to research activity mainly in the fields of urogenital radiology and breast imaging, with a special focus on MRI. Clinical activity is mainly centred on prostate MRI, female pelvis imaging and gastrointestinal and abdominal imaging.
Articles (11 in this collection)
-
-
-
-
Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance
Authors (first, second and last of 11)
-
Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance
Authors (first, second and last of 8)
-
-
MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance
Authors (first, second and last of 10)
-
Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
Authors (first, second and last of 15)
-
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
Authors (first, second and last of 10)
-
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
Authors (first, second and last of 13)
-
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
Authors (first, second and last of 13)
